All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Tue 1991-04-02? to Mon 2026-05-11 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| REGN × |
−9.59%
2026-05-11 |
13.84 TRR
2026-05-11 |
||||
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Tue 1991-04-02? to Mon 2026-05-11 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| REGN × |
+1,283.94%
+7.77%/yr |
+14.29%/yr
(R2=0.761) |
||||
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Tue 1991-04-02? to Mon 2026-05-11 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| REGN × |
$10,000.00
1991-04-02 |
$138,394.14
2026-05-11 |
||||
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Year | REGN |
|---|---|
| 2026 (YTD) | −9.59% |
| 2025 | +6.12% |
| 2024 | −21.17% |
| 2023 | +17.79% |
| 2022 | +7.31% |
| 2021 | +22.13% |
| 2020 | +26.94% |
| 2019 | −1.72% |
| 2018 | −2.51% |
| 2017 | +0.30% |
| 2016 | −33.75% |
| 2015 | +31.36% |
| 2014 | +47.93% |
| 2013 | +58.51% |
| 2012 | +203.37% |
| 2011 | +63.97% |
| 2010 | +33.77% |
| 2009 | +28.21% |
| 2008 | −24.04% |
| 2007 | +15.60% |
| 2006 | +23.13% |
| 2005 | +66.91% |
| 2004 | −39.36% |
| 2003 | −22.00% |
| 2002 | −35.79% |
| 2001 | −21.37% |
| 2000 | +167.52% |
| 1999 | +68.36% |
| 1998 | −15.23% |
| 1997 | −47.79% |
| 1996 | +22.41% |
| 1995 | +314.46% |
| 1994 | −81.15% |
| 1993 | +25.71% |
| 1992 | −35.66% |
| 1991 | −16.00% |
| Tue 1991-04-02? to Mon 2026-05-11 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| REGN × | −43.28% |
−92.82%
2005-04-14 |
||||
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Period ending Mon 2026-05-11 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| REGN × |
+31.36%/yr +31.53% total |
−16.47%/yr −30.24% total |
−4.10%/yr −11.81% total |
+2.96%/yr +15.71% total |
+3.39%/yr +39.52% total |
|
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||